Cardio News by LucidQuest: LVEF Trends, AI Dx & Xenotransplants

1 Views

  • Thanks! Share it with your friends!

    You disliked this video. Thanks for the feedback!

admin
Published
This week, LucidQuest distills nine breakthroughs. Global societies now urge tracking LVEF trajectories—rather than single cut-offs—to redefine heart-failure phenotypes. Sensydia’s pivotal CPS™ trial pursues catheter-free, acoustic pressure mapping. Real-world data show iRhythm’s Zio® boosts arrhythmia detection and halves repeat testing and cardiovascular events. GLP-1 receptor agonists cut atrial-fibrillation episodes independent of weight loss. Children’s Hospital LA pioneers pig-to-infant heart xenotransplants. CATIS-2 warns early blood-pressure reduction post-stroke may harm normotensive patients, while AdventHealth Orlando launches ECMO-assisted CPR for refractory arrest. ALT-SHOCK-2 finds early intra-aortic balloon pumping neutral in HF-related cardiogenic shock. Finally, an AI model mines routine bone scans in seconds, quantifying vascular calcification to predict cardiac risk.
Category
Cardiology
Be the first to comment

Up Next